×
Please click
here
if you are not redirected within a few seconds.
All
Maps
News
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
We're Hopeful That ORIC Pharmaceuticals (NASDAQ:ORIC) Will Use Its Cash Wisely
Simply Wall Street
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
9 hours ago
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance Canada
SOUTH SAN FRANCISCO and SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology...
5 days ago
ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
GlobeNewswire
Initiated three ORIC-114 Phase 1b expansion cohorts in NSCLC patients with EGFR exon 20 insertion, HER2 exon 20 insertion, or EGFR atypical...
2 days ago
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Recommendation of "Buy" by Analysts
MarketBeat
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) has been assigned a consensus rating of "Buy" from the six brokerages that are...
1 day ago
Oric Pharmaceuticals presents new PLK4 inhibitors
BioWorld MedTech
Oric Pharmaceuticals Inc. has divulged serine/threonine-protein kinase PLK4 (STK18) inhibitors reported to be useful for the treatment of...
2 weeks ago
Strs Ohio Makes New $72000 Investment in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)
Defense World
Strs Ohio purchased a new stake in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) in the 4th quarter, according to its...
6 days ago
ORIC Pharmaceuticals Stock: Rally Seems Overdone
Seeking Alpha
Summary. ORIC Pharmaceuticals' stock has seen significant gains since releasing promising data from its ORIC-114 program, which induced...
1 month ago
ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
Yahoo Finance
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage...
2 months ago
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 6.5%
MarketBeat
Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) rose 6.5% during mid-day trading on Tuesday .
1 day ago
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
GlobeNewswire
Presented initial Phase 1b data from three clinical programs that support potential best in class profiles, with ORIC-944 and ORIC-114...
1 month ago